JAMA Medical News

JAMA's Angel Desai, MD, speaks with Gary Marcus, PhD, coauthor of Rebooting AI: Building Artificial Intelligence We Can Trust. Marcus argues that endowing machines with intelligence will require innovation that embraces the complexity of the real world. Plus: How can AI be used during COVID-19? Related: Artificial Intelligence: Promise, Pitfalls, and Perspective

Convalescent Plasma for COVID-19; Prioritizing Physician Mental Health as COVID-19 Marches On; Global Effort to Collect Data on Ventilated Patients With COVID-19

The University of New Mexico's Eileen Barrett, MD, MPH, speaks with JAMA's Jennifer Abbasi about the pandemic's mental and emotional toll on health care workers—and how they and their employers can safeguard their well-being. Read the Article: Prioritizing Physician Mental Health as COVID-19 Marches On

Finding Ways to Reduce Coronavirus Exposure During Dialysis; The Promise and Peril of Antibody Testing for COVID-19; The Challenge of Preventing COVID-19 Spread in Correctional Facilities

Medical historian Howard Markel, MD, PhD, director of the University of Michigan's Center for the History of Medicine, speaks with JAMA Fishbein fellow Angel Desai, MD, about lessons from the devastating 1918 flu pandemic. Markel discusses his research into the effects of social distancing on US death rates during the worldwide outbreak. Pandemic Part 2: A Trip to Philadelphia’s Mutter Museum Read the article: Twentieth-Century Lessons for a Modern Coronavirus Pandemic

A new exhibit on the 1918 flu pandemic asks: What is an individual's responsibility to their community during a pandemic? Exhibit curator Jane Boyd and museum manager Nancy Hill take Jennifer Abbasi on a tour of the medical museum's new exhibit just weeks before the COVID-19 outbreak first emerged. Pandemic Part 1: 1918 Flu Pandemic and COVID-19 Read the article: Twentieth-Century Lessons for a Modern Coronavirus Pandemic

David Strauss, MD, PhD, of the FDA talks with Jennifer Abbasi about his recent studies in JAMA investigating sunscreen safety Related: FDA Trials Find Sunscreen Ingredients in Blood, but Risk Is Uncertain Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial

Fixing the Parent Trap for Resident Physicians; Confirmatory Trial For Drug to Prevent Preterm Birth Finds No Benefit, So Why Is It Still Prescribed?; The Low-FODMAP Diet Helps IBS Symptoms, but Questions Remain

Taking Medicine to the Streets to Care for Those Who Live There; Trauma-Informed Care May Ease Patient Fear, Clinician Burnout

The 2019 novel coronavirus (2019-nCoV) outbreak exemplifies ongoing biothreats to global security, as each new threat tests principles of preparation and response at national, regional, and clinical levels. Tom Inglesby, MD, director of the Center for Health Security at the Johns Hopkins Bloomberg School of Public Health, discusses biosecurity with Angel Desai, MD, JAMA Fishbein fellow.